Market Overview

Ignyta to be Added to Russell Microcap Index

Related RXDX
Moffitt Cancer Center and Ignyta, Inc. Enter into Cancer Research Collaboration for RXDX-106
Ignyta Announces PositiveInterim Data from RXDX-105 Phase 1 Clinical Trial at 2015 EORTC-NCI-AACR Conference

Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced that the company's shares will be added to the Russell Microcap® Index following Russell Investments' reconstitution of its comprehensive set of U.S. and global equity indexes after market close on June 27, 2014, according to a preliminary list of additions posted June 13, 2014 on

Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. Approximately $5.2 trillion in assets currently are benchmarked to them.

Posted-In: Earnings News Press Releases


Related Articles (RXDX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters